Imaging in Moyamoya Disease - Study to Investigate Different Imaging Technologies for a Better Understanding of Various Imaging Techniques to Evaluate Cerebral Hemodynamics, Disease-activity and Possibly the Etiology in Moyamoya Patients

Launched by UNIVERSITY HOSPITAL TUEBINGEN · Mar 19, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on improving the way we understand and treat Moyamoya Disease, a condition that affects blood flow to the brain. The study aims to explore different imaging technologies, like specialized MRI and PET scans, to better analyze how blood moves in the brain and to identify factors that may influence the progression of the disease. By doing so, researchers hope to create clearer guidelines for the imaging needed before and after surgery for patients with Moyamoya.

To participate in the study, individuals should have a suspicion of Moyamoya Disease and be able to provide informed consent, meaning they understand the study and agree to take part. Patients with certain conditions, like those caused by hardening of the arteries or pregnancy, may not be eligible. Participants will undergo various imaging tests and may contribute to a better understanding of this disease, which could lead to improved care for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with suspicion of Moyamoya Disease
• • Patients able to understand the study and to give their informed consent
• Exclusion Criteria:
• • Cerebral vascular disease caused by atherosclerosis
• • Vasculitis
• • Contraindications to MRI
• • Contraindications to PET/CT
• • Pregnancy
• • Inability to give informed consent
• • Renal insufficiency